Home Cart 0 Sign in  
X

[ CAS No. 31704-11-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 31704-11-7
Chemical Structure| 31704-11-7
Chemical Structure| 31704-11-7
Structure of 31704-11-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 31704-11-7 ]

Related Doc. of [ 31704-11-7 ]

Alternatived Products of [ 31704-11-7 ]

Product Details of [ 31704-11-7 ]

CAS No. :31704-11-7 MDL No. :MFCD00806415
Formula : C16H11N3 Boiling Point : -
Linear Structure Formula :- InChI Key :WQWLWMHHMQYNIE-UHFFFAOYSA-N
M.W : 245.28 Pubchem ID :723044
Synonyms :

Calculated chemistry of [ 31704-11-7 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 19
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 76.83
TPSA : 41.57 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.02
Log Po/w (XLOGP3) : 3.42
Log Po/w (WLOGP) : 3.78
Log Po/w (MLOGP) : 2.78
Log Po/w (SILICOS-IT) : 4.01
Consensus Log Po/w : 3.2

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.19
Solubility : 0.0159 mg/ml ; 0.0000647 mol/l
Class : Moderately soluble
Log S (Ali) : -3.97
Solubility : 0.0261 mg/ml ; 0.000106 mol/l
Class : Soluble
Log S (SILICOS-IT) : -6.74
Solubility : 0.0000449 mg/ml ; 0.000000183 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.76

Safety of [ 31704-11-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 31704-11-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 31704-11-7 ]

[ 31704-11-7 ] Synthesis Path-Downstream   1~7

  • 1
  • [ 100-69-6 ]
  • [ 31704-11-7 ]
  • [ 80477-74-3 ]
YieldReaction ConditionsOperation in experiment
57%
  • 2
  • [ 100-43-6 ]
  • [ 31704-11-7 ]
  • [ 80477-75-4 ]
YieldReaction ConditionsOperation in experiment
43.4%
  • 3
  • [ 491-35-0 ]
  • [ 95-54-5 ]
  • [ 31704-11-7 ]
YieldReaction ConditionsOperation in experiment
65% With sulfur at 160 - 170℃; for 10h;
YieldReaction ConditionsOperation in experiment
Rk. m. Et3N (Tab. III);
YieldReaction ConditionsOperation in experiment
/BRN= 205479/;
o-Phenylendiamin, Lepidin;
o-Phenylendiamin, 4-Methyl-chinolin, S;
  • 6
  • [ 491-35-0 ]
  • [ 88-74-4 ]
  • [ 31704-11-7 ]
YieldReaction ConditionsOperation in experiment
83% With iron; sulfur at 150℃; for 24h; Inert atmosphere;
  • 7
  • [ 4363-93-3 ]
  • [ 95-54-5 ]
  • [ 31704-11-7 ]
YieldReaction ConditionsOperation in experiment
59% In methanol at 65℃; for 1.5h; Molecular sieve; chemoselective reaction; 4.2.1 Typical experimental procedure for the synthesis of 2-arylbenzimidazoles: General procedure: o-Phenylenediamine (1, 260mg, 2.4mmol) and 3,4,5-trimethoxybenzaldehyde (2, 392mg, 2mmol) were dissolved in methanol (15mL). To this reaction mixture, 1g molecular sieves 3Å were added and reaction mixture was refluxed for 1.5h. On completion, it was filtered and solvent was evaporated. The residue was purified through column chromatography over silica gel (60-120 mesh) and eluted with hexane-chloroform. Compound 1,2-diarylbenzimidazole (4e) was eluted at 70% chloroform-hexane polarity followed by 2-arylbenzimidazole (3e) at 2% acetone-chloroform.
52% With silica gel In dichloromethane at 20℃;
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 31704-11-7 ]

Quinolines

Chemical Structure| 1006589-08-7

[ 1006589-08-7 ]

3-(1H-Imidazol-2-yl)quinoline

Similarity: 0.86

Chemical Structure| 1006589-08-7

[ 1006589-08-7 ]

3-(1H-Imidazol-2-yl)quinoline

Similarity: 0.86

Benzimidazoles

Chemical Structure| 2208-59-5

[ 2208-59-5 ]

2-(Pyridin-4-yl)-1H-benzo[d]imidazole

Similarity: 0.93

Chemical Structure| 2562-81-4

[ 2562-81-4 ]

2-(Naphthalen-1-yl)-1H-benzo[d]imidazole

Similarity: 0.93

Chemical Structure| 64263-00-9

[ 64263-00-9 ]

5,6-Dimethyl-2-(pyridin-4-yl)-1H-benzo[d]imidazole

Similarity: 0.91

Chemical Structure| 2208-59-5

[ 2208-59-5 ]

2-(Pyridin-4-yl)-1H-benzo[d]imidazole

Similarity: 0.93

Chemical Structure| 2562-81-4

[ 2562-81-4 ]

2-(Naphthalen-1-yl)-1H-benzo[d]imidazole

Similarity: 0.93